Top Biosimilars Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Biosimilars Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Biosimilars industry players.

Biosimilars Market Competitive Landscape

The global biosimilars market has turned out to be a competitive and dynamic market.Major pharmaceutical and biotech firms are investing heavily in biosimilars to capitalize on market opportunities arising from the patent loss of blockbuster biologic medicines. Companies are concentrating on the development of biosimilars against high-revenue biologics, with high concentration on broadening the pipeline of biosimilars into fusion proteins, insulins, and monoclonal antibodies. For example, Sandoz (Novartis), being one of the leaders in the biosimilars market, is now concentrating on oncology and immunology biosimilars, including Zarxio (biosimilar of Neupogen) and Erelzi (biosimilar of Enbrel).

Top Players in Biosimilars Market

  • Biocon Biologics (India) 
  • Celltrion (South Korea) 
  • Sandoz (Switzerland) 
  • Fresenius Kabi (Germany) 
  • Teva Pharmaceuticals (Israel) 
  • Amgen (USA) 
  • Mylan (USA) 
  • Coherus BioSciences (USA) 
  • Alvotech (Iceland) 
  • Polpharma Biologics (Poland) 
  • Accord Healthcare (United Kingdom) 
  • Formycon (Germany) 
  • Pfizer (USA)
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Biosimilars Market size was valued at USD 24.3 billion in 2023 and is poised to grow from USD 28.38 billion in 2024 to USD 98.31 billion by 2032, growing at a CAGR of 16.8% during the forecast period (2025-2032).

Some of the notable contributors include Pfizer, Novartis (Sandoz), Amgen, Biocon Biologics, Samsung Bioepis, and Celltrion. These players use cutting-edge manufacturing, biosimilar interchangeability strategies, and competitive pricing to battle in the market. Some of the upcoming players such as Alvotech, Coherus BioSciences, and Polpharma Biologics are also emerging, making a difference through innovation and affordability. As biosimilar adoption increases, competition intensifies, fostering market growth and affordability of biologic treatments globally.

The growing prevalence of chronic diseases like cancer, diabetes, and autoimmune diseases is propelling the need for cheap biologic treatments. Biosimilars ensure cheaper substitutes to pricey biologics, enhancing patients' access to life-sustaining medicines. This surging demand for long-term therapeutic solutions continues to boost uptake for biosimilar drugs.

Regulatory bodies such as the FDA and EMA are simplifying biosimilar approval procedures, resulting in more market entries. Faster approvals encourage competition, driving down costs and expanding accessibility. Healthcare providers and payers are more inclined to adopt biosimilars, causing a surge in market penetration and reshaping pricing strategies for both originator biologics and biosimilars.

North America continues to lead the global biosimilars market share, driven by a robust regulatory framework, significant R&D investments, and a surge in biosimilar approvals.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Insulin Biosimilars Market
Buy Now GET FREE SAMPLE
Biobanking Market
Buy Now GET FREE SAMPLE
Biosimulation Market
Buy Now GET FREE SAMPLE
Bioethanol Market
Buy Now GET FREE SAMPLE
Biochip Market
Buy Now GET FREE SAMPLE
Biotech Ingredients Market
Buy Now GET FREE SAMPLE
Biopharmaceuticals Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Biosimilars Market Report Thumbnail by SkyQuest Technology
Biosimilars Market

Report ID: SQMIG35H2341

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE